Clinical Trial Update: A New Study Evaluating the Activity of Modular CAR T for mYeloma [Phase 1]

View source ↗

Summary

A Phase 1 study at University College London is evaluating the activity of Modular CAR T therapy in patients with multiple myeloma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Modular CAR T

Snippet

Sponsor: University College, London | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING